{
  "id": 181304,
  "name": "BD (BECTON, DICKINSON AND COMPANY)",
  "slug": "bd-becton-dickinson-and-company",
  "state": "NJ",
  "description": "BD is a medical device technology company.",
  "totalSpending": 1830000,
  "filings": 30,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 210000
    },
    {
      "year": 2019,
      "income": 180000
    },
    {
      "year": 2020,
      "income": 180000
    },
    {
      "year": 2021,
      "income": 240000
    },
    {
      "year": 2022,
      "income": 300000
    },
    {
      "year": 2023,
      "income": 240000
    },
    {
      "year": 2024,
      "income": 240000
    },
    {
      "year": 2025,
      "income": 240000
    }
  ],
  "firms": [
    "TARPLIN, DOWNS & YOUNG, LLC"
  ],
  "lobbyists": [
    "RAISSA DOWNS",
    "JENNIFER YOUNG",
    "MICHELLE EASTON",
    "ELIZABETH MURRAY",
    "CHARLOTTE IVANCIC",
    "PAMELA SMITH",
    "EMILY MURRY",
    "KIMBERLY BRANDT",
    "MARGARET JOSEPH",
    "PETER FISE",
    "LAURA FRIEDEL",
    "PARICK CARROLL"
  ],
  "issues": [
    "MMM",
    "TAX",
    "HCR",
    "BUD",
    null,
    "ENV",
    "TRD"
  ],
  "sampleDescriptions": [
    "Medicare coverage and reimbursement, diagnostics, flow cytometry, Unique Device Identifier, diagnostics, ESRD, Syringes, opioid diversion\nS. 794 - Medicare coverage\nS. 870 - Chronic care\nS. 1827 - Kids Act of 2017\nH.R. 3921 - Healthy Kids Act",
    "H.R. 184 - Protect Medical Innovation Act of 2017\nS. 108 - Medical Device Access and Innovation Protection Act\nH.R. 1628 - American Health Care Act of 2017",
    "PL 114-255 - 21st Century Cures, implementation\nH.R. 2430 - FDA Reauthorization Act of 2017\nH.R. 6 - SUPPORT for Patients and Communities Act\nS. 3120 - HEAL Substance Use Disorders Act\nS. 2680 - Opioid Crisis Response Act\n\n\n***, no specific bills, FDA related issues, diagnostics, drug shortages, compounding, pandemic preparedness, health IT, opioid safety, anti-microbial resistance, hazardous drug safety, VA procurement, medical technology regulation",
    "budget resolution, reconciliation, deficit reduction, debt ceiling, NIH Funding\nH.R. 1625 - Consolidated Appropriations Act of 2018\nH.R. 1892 - Bipartisan Budget Act of 2018\n2019 Appropriations",
    "budget resolution, reconciliation, deficit reduction, debt ceiling, NIH Funding\nH.R. 1625 - Consolidated Appropriations Act of 2018\nH.R. 1892 - Bipartisan Budget Act of 2018\nH.R. 6157 - HHS appropriations and continuing resolution",
    "PL 114-255 - 21st Century Cures, implementation\nH.R. 2430 - FDA Reauthorization Act of 2017\nH.R. 6 - SUPPORT for Patients and Communities Act\nS. 3120 - HEAL Substance Use Disorders Act\nS. 2680 - Opioid Crisis Response Act\nS. 2852 - Pandemic and All Hazards Preparedness Act \n\n\n***, no specific bills, FDA related issues, diagnostics, drug shortages, compounding, pandemic preparedness, health IT, opioid safety, anti-microbial resistance, hazardous drug safety, VA procurement, medical technology regulation",
    "PL 114-255 - 21st Century Cures, implementation\nH.R. 2430 - FDA Reauthorization Act of 2017\nH.R. 6 - SUPPORT for Patients and Communities Act\nS. 3120 - HEAL Substance Use Disorders Act\nS. 2680 - Opioid Crisis Response Act\nS. 2852 - Pandemic and All Hazards Preparedness Act \n\n\n***, no specific bills, FDA related issues, diagnostics, drug shortages, compounding, pandemic preparedness, health IT, opioid safety, anti-microbial resistance, hazardous drug safety, VA procurement, medical technology regulation, artificial intelligence",
    "budget resolution, reconciliation, deficit reduction, debt ceiling, NIH Funding\nH.R. 1625 - Consolidated Appropriations Act of 2018\nH.R. 1892 - Bipartisan Budget Act of 2018\nH.R. 6157 - HHS appropriations and continuing resolution\nH.R. 695 - Department of Defense Appropriations Act",
    "H.R. 2207/S.692 - Protect Medical Innovation Act of 2019\n\nno specific bill, tariff and trade policies",
    "debt ceiling, NIH Funding\nH.R. 2740 - HHS Appropriations, 2020\nH.R. 3164 - FDA Appropriations, 2020",
    "no specific bills, FDA related issues,diagnostics, pandemic preparedness, health IT, opioid safety, anti-microbial resistance, hazardous drug safety, VA procurement, medical technology regulation, artificial intelligence, cybersecurity, privacy, medication safety & drug diversion, ESRD\n\nS. 1895 - Lower Health Care Costs Act",
    "Medicare coverage and reimbursement, diagnostics, flow cytometry, Unique Device Identifier, diagnostics, ESRD, Syringes, opioid diversion, artificial intelligence",
    "no specific bills, FDA related issues,diagnostics, pandemic preparedness, health IT, opioid safety, anti-microbial resistance, hazardous drug safety, VA procurement, medical technology regulation, artificial intelligence, cybersecurity, privacy, medication safety & drug diversion, ESRD\n\nS. 1895 - Lower Health Care Costs Act \nH.R. 2064 - Sunshine for Samples Act",
    "debt ceiling, NIH Funding\nH.R. 2740 - HHS Appropriations, 2020\nH.R. 3164 - FDA Appropriations, 2020\nH.R. 4378 - Continuing Appropriations Act and Health Extenders Act",
    "H.R. 2207/S.692 - Protect Medical Innovation Act of 2019\n\nno specific bill, tariff and trade policies\n\nH.R. 1865 - Further Consolidated Appropriations Act, 2020",
    "debt ceiling, NIH Funding\nH.R. 4378 - Continuing Appropriations Act and Health Extenders Act\nH.R. 1865 - Further Consolidated Appropriations Act, 2020\nH.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act",
    "no specific bills, FDA related issues,diagnostics, pandemic preparedness, health IT, opioid safety, anti-microbial resistance, hazardous drug safety, VA procurement, medical technology regulation, artificial intelligence, cybersecurity, privacy, medication safety & drug diversion, ESRD, coronavirus response \n\nS. 1895 - Lower Health Care Costs Act \nH.R. 2064 - Sunshine for Samples Act\nH.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020\nH.R. 6201 - Families First Coronavirus Response Act\nS. 3548 - CARES Act\nH.R. 6800 - The Heroes Act",
    "debt ceiling, NIH Funding\nH.R. 4378 - Continuing Appropriations Act and Health Extenders Act\nH.R. 1865 - Further Consolidated Appropriations Act, 2020\nH.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act\nH.R. 8337 - Continuing Appropriations Act of 2021",
    "debt ceiling, NIH Funding\nH.R. 4378 - Continuing Appropriations Act and Health Extenders Act\nH.R. 1865 - Further Consolidated Appropriations Act, 2020\nH.R. 3055 - Further Continuing Appropriations Act, 2020, and Further Health Extenders Act\nH.R. 8337 - Continuing Appropriations Act of 2021\nH.R. 133 - Consolidated Appropriations Act, 2021",
    "H.R. 2207/S.692 - Protect Medical Innovation Act of 2019\nH.R. 1865 - Further Consolidated Appropriations Act, 2020\n\nno specific bill, tariff and trade policies"
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 14,
  "trajectory": "stable",
  "yearsActive": 8,
  "avgAnnualSpending": 228750,
  "peakYear": 2022,
  "lobbyistCount": 12,
  "firmCount": 1,
  "issueCount": 6
}